- Home » News and EventsPage 25
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent To Present Case Studies In Expediting Biologic Development At BioProcess International (BPI) East Conference
Aug 29, 2019
Catalent today announced that Steve Hager, Ph.D., Senior Director, Technical Support will present at the BioProcess International (BPI) East Conference, to be held at the Boston Convention and Exhibition Center, Boston, on Sept. 9 – 12, 2019
Catalent Expert Invited to Present on Maximizing Early Drug Development at the Prague-Weizmann Summer School
Aug 22, 2019
Catalent, today announced that Rob Harris, Ph.D., Director, Science & Technology has been invited to present at the upcoming 6th Prague-Weizmann “Advances in Drug Discovery” Summer School, to be held at Masaryk College, Prague, Czech Republic on Sept. 2 – 6, 2019.
Novavax And Catalent Announce Closing Of Strategic Partnership
Jul 31, 2019
Novavax, Inc. and Catalent Biologics’ Paragon Gene Therapy unit today announced the closing of their previously announced arrangement.
Catalent Appoints Ricardo Pravda To Lead Human Resources Function
Jul 18, 2019
Catalent today announced it has appointed Ricardo Pravda as Senior Vice President and Chief Human Resources (HR) Officer. Mr. Pravda reports to John Chiminski, Catalent’s Chair and CEO, joining the company’s executive leadership team.
Catalent Biologics Announces Agreement To Provide Additional Production Of Approved Gene Therapy Treatment For Spinal Muscular Atrophy
Jul 16, 2019
Catalent Biologics today announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for spinal muscular atrophy (SMA).
Catalent To Present Scientific Innovations And Lead Drug Delivery Discussions At The Controlled Release Society Annual Meeting
Jul 10, 2019
Catalent today announced that Cornell Stamoran, Ph.D., founder of Catalent’s Applied Drug Delivery Institute, has been invited to chair multiple sessions at the upcoming CRS Annual Meeting and Exposition in Valencia, Spain.
Catalent’s Partner, Passage Bio, Announces New Dedicated Gene Therapy Manufacturing Suite
Jul 10, 2019
The dedicated cGMP suite is to be built under strategic partnership with Paragon Gene Therapy to support future clinical and commercial production for Passage Bio’s AAV-delivered gene therapies
Catalent Extends Global Commercial Spray Drying Capabilities In Europe
Jul 9, 2019
Catalent today announced that it has significantly expanded the capacity of its global spray drying operations through an agreement with Sanofi Active Ingredient Solutions, an industrial platform of Sanofi…
The Use Of Continuous Chromatography In Effective Process Design To Be Presented By Catalent Biologics Expert At PREP Symposium
Jul 2, 2019
Catalent today announced that Ben Kester, Manager and Senior Scientist, Purification Development, Catalent Biologics, will present at the upcoming 32nd International PREP Symposium.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.